首页> 外国专利> METHOD FOR OPTIMIZING PERIOPERATIVE PERIOD OF ELDERLY AND SENILE PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN SURGICAL TREATMENT OF LUNG CANCER

METHOD FOR OPTIMIZING PERIOPERATIVE PERIOD OF ELDERLY AND SENILE PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN SURGICAL TREATMENT OF LUNG CANCER

机译:肺癌外科治疗慢性缺血性心脏病围手术期优化围手术期和老年患者的方法

摘要

FIELD: medicine. ;SUBSTANCE: invention relates to medicine, namely to anesthesiology and resuscitation in oncology, and can be used to optimize the perioperative period of patients with chronic coronary heart disease of elderly and senile age in the surgical treatment of lung cancer. Before the start of surgery, puncture and catheterization of the epidural space are performed at the Th 3 - Th 4 level. Identification tests are carried out. A test dose of lidocaine 2%, 2.0 ml is administered. If the result is negative, the catheter is fixed, an aseptic dressing is applied and a micro-jet injection of a local anesthetic solution at a dose of 10 ml/hour is started into the epidural space. After induction and intubation of the trachea, intravenous administration of levosimendan through an infusomat is started at a rate of 0.1 mcg/kg/min. After the surgical intervention, during the first 48 hours, the micro-jet administration of levosimendan at the previous therapeutic dose and the epidural administration of the solution are continued for 6 days. ;EFFECT: method provides the possibility of radical surgical treatment of lung cancer in elderly and elderly patients with subcompensated comorbid pulmonary-cardiac pathology, without aggravating the course of concomitant pathology, creates a favorable background for the course and prognosis of the postoperative period. ;1 cl, 1 ex
机译:领域:医学。 ;物质:发明涉及医学,即肿瘤学中的麻醉和复苏,并且可用于优化老年人慢性冠心病患者的围手术期,在肺癌外科治疗中的慢性冠心病。在手术开始之前,硬膜外空间的穿刺和导管在第3级进行。进行识别测试。施用Lid Caine 2%,2.0ml的试验剂量。如果结果是否定的,则导管是固定的,施加无菌敷料,并且在10mL /小时的剂量下施用微喷射局部麻醉溶液。在气管诱导和插管时,通过infusomat静脉内施用Levosimendan以0.1mcg / kg / min的速率开始。手术干预后,在前48小时内,继续治疗剂量和溶液硬膜外施用的微喷射施用6天。 ;效果:方法提供老年人和老年人肺癌肺癌的激进手术治疗的可能性,而不加剧伴随病理的过程,为术后期的课程和预后创造了有利的背景。 ; 1 cl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号